Liam Wong

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Laboratory-based testing does not allow for the sufficiently rapid return of data to enable optimal therapeutic monitoring of patients with metabolic diseases such as phenylketonuria (PKU). The typical turnaround time of several days for current laboratory-based testing is too slow to be practically useful for effective monitoring or optimizing therapy.(More)
  • 1